1-3 of 3
Reid Merryman
Close
Sort by
Journal Articles

Recommendations for managing PD-1 blockade in the context of allogeneic HCT in Hodgkin lymphoma: taming a necessary evil

Clinical Trials & Observations
Charles Herbaux, Reid Merryman, Steven Devine, Philippe Armand, Roch Houot, Franck Morschhauser, Bradley Haverkos
Journal: Blood
Blood (2018) 132 (1): 9–16.
https://doi.org/10.1182/blood-2018-02-811174
Published: 2018
Journal Articles

PD-1 blockade for relapsed lymphoma post–allogeneic hematopoietic cell transplant: high response rate but frequent GVHD

Clinical Trials & Observations
Bradley M. Haverkos, Diana Abbott, Mehdi Hamadani, Philippe Armand, Mary E. Flowers, Reid Merryman, Manali Kamdar, Abraham Sebastian Kanate, Ayman Saad, Amitkumar Mehta, Siddhartha Ganguly, Timothy S. Fenske, Parameswaran Hari, Robert Lowsky, Leslie Andritsos, Madan Jagasia, Asad Bashey, Stacey Brown, Veronika Bachanova, Deborah Stephens, Shin Mineishi, Ryotaro Nakamura, Yi-Bin Chen, Bruce R. Blazar, Jonathan Gutman, Steven M. Devine
Journal: Blood
Blood (2017) 130 (2): 221–228.
https://doi.org/10.1182/blood-2017-01-761346
Published: 2017
Includes: Supplemental data
Journal Articles

Asparaginase-Associated Myelosuppression and Effects on Dosing of Other Chemotherapeutic Agents In Children and Adolescents with Acute Lymphoblastic Leukemia

Reid Merryman, William J. Gostic, II, Kristen E. Stevenson, Donna Neuberg, ScD, Jane O'Brien, Stephen E. Sallan, MD, Lewis B. Silverman, MD
Journal: Blood
Blood (2010) 116 (21): 3249.
https://doi.org/10.1182/blood.V116.21.3249.3249
Published: 2010